Resoclip

Company Overview

Snapshot

Founded in May 2025, Resoclip operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its core technology.

Business overview

Resoclip is a Health Tech & Life Sciences company specializing in medical devices. It develops fully biodegradable, implantable marker clips designed for accurate soft-tissue localization during diagnostic and interventional procedures. The core technology involves a proprietary polymer blend that ensures visibility across common imaging modalities like mammography, ultrasound, CT, and MRI, followed by natural resorption. This innovation aims to reduce the reliance on permanent metallic markers and eliminate the need for potential follow-up removal. Resoclip targets applications in breast and colorectal soft-tissue localization, with future potential in theragnostic applications such as local drug delivery.

Company Intelligence Q&A

What is Resoclip's primary product?

Resoclip develops fully biodegradable, implantable marker clips used for accurate soft-tissue localization during diagnostic and interventional procedures.

What imaging modalities are compatible with Resoclip's markers?

Resoclip's marker clips are designed to be visible across common imaging modalities, including mammography, ultrasound, CT, and MRI.

What is the key benefit of Resoclip's technology?

The key benefit is that the marker clips naturally resorb after a predetermined period, reducing the need for permanent metallic markers and potential follow-up removal.

When was Resoclip founded?

Resoclip was founded in May 2025.

What markets does Resoclip currently target?

Resoclip currently targets use cases such as breast and colorectal soft-tissue localization, with potential future theragnostic applications.